Coraline Duménil
Université de Versailles Saint-Quentin-en-Yvelines(FR)Hôpital Ambroise-Paré(FR)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, Cancer Cells and Metastasis
Most-Cited Works
- → Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis(2018)220 cited
- → Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab(2018)172 cited
- → Immunotherapy revolutionises non-small-cell lung cancer therapy: Results, perspectives and new challenges(2017)111 cited
- → Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab(2019)96 cited
- → Circulating tumor DNA evaluated by Next-Generation Sequencing is predictive of tumor response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer(2018)82 cited
- → Clinical factors associated with early progression and grade 3–4 toxicity in patients with advanced non-small-cell lung cancers treated with nivolumab(2018)58 cited
- → Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression(2020)36 cited
- → Plasma Biomarkers and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: New Tools for Better Patient Selection?(2019)29 cited
- → Combination of Crizotinib and Osimertinib or Erlotinib Might Overcome MET-Mediated Resistance to EGFR Tyrosine Kinase Inhibitor in EGFR-Mutated Adenocarcinoma(2018)25 cited
- → Baseline Hedgehog Pathway Activation and Increase of Plasma Wnt1 Protein Are Associated with Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer(2021)25 cited